- In April 2024, Thermo Fisher Scientific announced the expansion of its Grand Island, New York facility to increase the production of animal-origin-free and chemically defined cell culture media. This move aims to meet growing demand from vaccine manufacturers and cell therapy developers, reinforcing Thermo Fisher’s leadership in supplying high-quality, GMP-compliant media solutions across North America and supporting scalability in advanced therapeutic applications
- In March 2024, GE HealthCare’s Cytiva division collaborated with the University of Toronto’s Medicine by Design initiative to co-develop specialized stem cell culture media tailored for regenerative medicine research. This partnership reflects a commitment to innovation in academic-industry collaborations and the advancement of next-generation therapies through optimized, customizable media platforms
- In February 2024, Lonza Group expanded its Portsmouth, New Hampshire bioproduction site to enhance capabilities in producing clinical- and commercial-grade media for biologics manufacturing. The investment focuses on increasing capacity for serum-free and chemically defined formulations, aiming to support growing demand from North American biopharmaceutical clients pursuing monoclonal antibody and cell therapy pipelines
- In January 2024, Avantor, Inc. launched a new line of performance-enhanced classical media designed for cell-based assays and preclinical drug development. The launch, targeting U.S.-based pharmaceutical research labs, emphasizes batch-to-batch consistency and reduced contamination risk, supporting drug discovery and high-throughput screening workflows in regulated environments
- In December 2023, Corning Incorporated announced a strategic initiative with Canadian biotech startups to co-develop media supplements for 3D cell culture and organoid growth. The collaboration aims to advance in vitro disease modeling and drug testing, addressing the increasing demand for complex media systems in cancer biology and personalized medicine applications across Canada
